September 14, 2010
Newark, Calif. - Morpho Detection, Inc., part of Morpho, Safran group’s security business, today announced it has provided MobileTrace® and Hardened MobileTrace® systems in support of a recent Transportation Security Administration (TSA) pilot program that tested the application of mobile advanced explosives detection technology solutions. The field pilot took place at surface transportation sites in [...]
Launch of Two New Platforms for Microplate Analysis by Molecular Devices, Inc
September 14, 2010
Sunnyvale, Calif. - Molecular Devices, Inc., a long-time leader in bioanalytical systems for microplate analysis, today announced the launch of two new multi-mode detection platforms that expand its portfolio of microplate readers, enabling the company to meet all combinations of customer needs now and into the future. Both products will be showcased at Miptec 2010, [...]
LGC Standards Partners with Reinnervate to Bring ec23® to Life Science Researchers
September 14, 2010
ec23 enables consistent and reliable differentiation of stem cells to neurons LGC Standards is delighted to announce the addition of ec23®, a stable synthetic retinoid used for stem cell differentiation, to its portfolio of life science research and drug discovery products. ec23 is a proprietary molecule designed by the scientists at Reinnervate, an innovative life [...]
Sigma® Life Science to Supply Oligonucleotides to Research Councils UK
September 14, 2010
St. Louis, MO. - Sigma® Life Science, a division of Sigma-Aldrich® Corporation and a leading European manufacturer of oligonucleotides, has signed a three-year contract with Research Councils UK (RCUK) Shared Services Centre Limited to be a prefered supplier for synthetic oligonucleotides. With more than 20 years of experience in oligonucleotide synthesis, Sigma Life Science offers [...]
September 14, 2010
Sunnyvale, Calif. - Molecular Devices, Inc. today announced the launch of its new corporate website. The infrastructure of the new site is focused on its three main audience segments: Drug Discovery Scientists (BioPharma), Life Science Researchers (BioResearch), and Bioassay/Test Developers (BioTesting). Molecular Devices has a singular focus on helping its customers-both existing and prospective--succeed. This [...]
PSSE Introduces “LuBEA® system” at “BIOTECHNICA”
September 14, 2010
BIOTECHNICA 2009, focusing on R&D in the life science technology, was held from October 5, 2009 to October 7, 2009 in Hanover, Germany. About 11 thousand visitors from more than 40 countries gathered, while 650 companies from 28 countries participated in the event. Those figures were larger than last year’s. As the attendance of many [...]
Oxford Nanopore strengthens collaboration with University of Oxford
September 14, 2010
Oxford, UK. Oxford Nanopore Technologies Ltd is pleased to announce a new agreement to strengthen the Company’s collaboration with the University of Oxford. The Company will fund research in the laboratories of Professor Hagan Bayley and will partner exclusively with the University to develop revolutionary products for molecular analysis from these new discoveries. Research projects [...]
ITT to Enhance its Global Analytical Instrumentation Business with Acquisition of O.I. Corporation
September 14, 2010
WHITE PLAINS, N.Y., and COLLEGE STATION, Texas - ITT Corporation (NYSE:ITT) and O.I. Corporation (NASDAQ:OICO) today announced that they have entered into a definitive agreement for ITT to acquire all outstanding shares of O.I. Corporation, "OI", for approximately $29 million. OI's Board of Directors has unanimously approved the transaction, which is subject to approval from [...]
Oxford Nanopore Congratulates Professor Reza Ghadiri and Collaborators on $5.1 million NHGRI grant
September 14, 2010
Award will support research into sequencing of single stranded DNA using a protein nanopore Oxford, UK. Oxford Nanopore Technologies Ltd is pleased to congratulate Professor Reza Ghadiri (Scripps Institute, CA, USA) on the award of a $5.1 million, four year grant by the National Human Genome Research Institute (NHGRI). Professor Ghadiri will collaborate with Oxford [...]
TriLink BioTechnologies, Inc. Announces License Agreement with Biofortuna Ltd.
September 14, 2010
SAN DIEGO - TriLink BioTechnologies, Inc. (TriLink) announced that it has signed a licensing agreement with Biofortuna Ltd. (Biofortuna) for use of CleanAmp™ dNTPs in Biofortuna’s freeze dried in vitro diagnostic PCR kits. Biofortuna is developing a range of unique HLA diagnostic kits which will address the transplantation, blood grouping, disease identification and pharmacogenetic markets. [...]

